Laurus Labs files for Rp10bn Indian IPO
Indian pharmaceutical firm Laurus Labs is planning to go public this year with a Rp10bn ($149.0m) IPO, according to sources familiar with the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts